Evidence map›Paper›PMID 19439155›Full record

Trial reportAnnals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists

Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study.

Roseanne Defronzo Dobkin, Matthew Menza, Lesley A Allen, Humberto Marin, Karina L Bienfait, Jade Tiu, Jennifer Howarth

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05346445 (Citalopram Improves Vasomotor and Urogenital Syndromes in Mexican Patients With Post-menopause), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05346445 nacompletednot on this map

Citalopram Improves Vasomotor and Urogenital Syndromes in Mexican Patients With Post-menopause

TypeinterventionalSponsorHospital Regional 1o de OctubreRan2021 to 2021Enrolled91ConditionsPostmenopause, Hot FlashesArmsFluoxetine 20 MG, Citalopram 20mg
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Escitalopram treatment of menopausal hot flashes.Menopause (New York, N.Y.) · 2011
    Trial
  6. Trial
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Roseanne Defronzo DobkinDepartment of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA. dobkinro@umdnj.edu
Matthew Menza
Lesley A Allen
Humberto Marin
Karina L Bienfait
Jade Tiu
Jennifer Howarth
Johnson University · US

Funding

Treating Depression in Parkinson's Disease: A New MethodK23NS052155 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DOBKIN, ROSEANNE D · 2007 to 2011
$957k
NINDS NIH HHS K23 NS052155
6 · The paper itself

Abstract

backgroundHot flashes are one of the most troubling manifestations of menopause, affecting about 80% of women. Due to recent controversies about hormone replacement therapy, many women seek alternative treatments. The use of antidepressants to treat hot flashes and other menopausal symptoms has been an active area of investigation. However, the majority of past research in this area has included women with significant medical or psychiatric histories that may influence treatment response. This was the first study to examine the impact of escitalopram on hot flashes, mood, sleep, and quality of life in a sample of healthy nondepressed menopausal women.

methodsThis study enrolled 25 menopausal women who had no significant psychiatric or medical history. All women were treated with escitalopram (10 to 20 mg flexibly dosed) for 8 weeks. The active treatment phase was preceded by a single-blind placebo lead-in period.

resultsOver the course of the study, women reported significant decreases in both hot flash frequency and severity as well as improvements in dysphoria, anxiety, quality of life, and sleep.

conclusionThese preliminary findings suggest that escitalopram may be a feasible and effective option for treating hot flashes and other menopausal symptoms in healthy women who might not ordinarily consider antidepressant treatment.

Indexed as

MenopauseCitalopramDepressionDiagnostic and Statistical Manual of Mental DisordersEstrogen Replacement TherapyFemaleHot FlashesHumansMiddle AgedPilot ProjectsQuality of LifeSelective Serotonin Reuptake InhibitorsSeverity of Illness IndexSingle-Blind MethodSurveys and QuestionnairesCitalopramSelective Serotonin Reuptake Inhibitors

Identifiers

PMID19439155
PMCPMC2683354
OpenAlexW1463252448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.